Autocrine thrombospondin partially mediates TGF-β1-induced proliferation of vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 279, Issue 5 48-5, 2000, Pages

  Sajid, Mansoor ^a   Lele, Manjiri ^a   Stouffer, George A ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Angioplasty; Extracellular matrix; Receptors; Transforming growth factor; Vitronectin

Indexed keywords

INTEGRIN; STRESS ACTIVATED PROTEIN KINASE; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; VITRONECTIN;

ANGIOPLASTY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CELL PROLIFERATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0033662588     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.279.5.h2159     Document Type: Article

References (36)

1. Type β transforming growth factor in human platelets: Release during platelet degranulation and action on vascular smooth muscle cells
2. Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-β through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway
3. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling
4. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop
5. Stimulation of migration of human aortic smooth muscle cells by vitronectin: Implications for atherosclerosis
6. Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery
7. Vascular smooth muscle cell growth arrest on blockade of thrombospondin-1 requires p21(Cip1/WAF1)
8. Influence of transforming growth factor β1 (TGF-β1) on the behaviour of porcine thyroid epithelial cells in primary culture through thrombospondin-1 synthesis
9. Thrombospondin-1 is a major activator of TGF-β 1 in vivo
10. A monoclonal antibody against human thrombospondin inhibits platelet aggregation
11. Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent
12. Integrins on rat osteoclasts: Characterization of two monoclonal antibodies (F4 and F11) to rat β 3
13. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development
14. Regulation of vascular smooth muscle cell integrin expression by transforming growth factor β1 and by platelet-derived growth factor-BB
15. Transforming growth factor [β1 is a powerful modulator of platelet-derived growth factor action in vascular smooth muscle cells
16. 3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor
17. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation
18. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β
19. Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor
20. Production of transforming growth factor β1 during repair of arterial injury
21. Decreased type II/type I TGF-B receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-β 1
22. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury
23. Physiology of thrombospondin
24. 2-terminal kinase and progression through the G 1 phase of the cell cycle
25. Transforming growth factor-β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells
26. Thrombospondin- 1 is a powerful mitogen and chemoattractant for human vascular smooth muscle cells
27. Cyclic AMP inhibition of thrombininduced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression
28. 3 integrins, nonmuscle myosin heavy chain-A, and focal adhesion kinase form in thrombospondin-treated smooth muscle cells
29. Isolation and characterization of thrombospondin
30. Soluble transforming growth factor-β type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth
31. 3 Integrins are upregulated following vascular injury and mediate proliferation of cultured smooth muscle cells
32. TGF-β promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms
33. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-β isoforms and their receptors following arterial injury
34. Antibodies against transforming growth factorial suppress intimal hyperplasia in a rat model
35. Osteopontin-stimulated vascular smooth muscle cell migration is mediated by β 3 integrin
36. Hematopoietic progenitor kinase 1 is a component of transforming growth factor β-induced c-Jun N-terminal kinase signaling cascade